Merck KGaA
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
549 / 1328
Position in country
454 / 963
Return on Assets, %
5.7
-2.7
Net income margin, %
11.2
2.8
EBITDA margin, %
24.7
10.8
Debt to Equity, %
36.9
19.2
Intangible assets and goodwill, %
50.3
3.6
Revenue CAGR 3Y, %
6.1
8.5
Total Equity change 1Y, %
6.1
0
Revenue Y, % chg
-2.5
0.5
P/E
23.4
22.7
P/BV
2.4
1.5
P/S
3.1
2.3
EV/S
3.5
2.4
EV/EBITDA
12.7
7.4
Average Analyst recommendation
Strong buy
Strong buy
Average upside forecasts, %
13.2
51.3
Forward P/E
4.8
15.6
Dividend Yield, %
1.4
1.7
Forward Dividend Yield, %
5.4
0.2
Expected dividend per share
1.7
0
Payout Ratio, %
10
30.3
Dividend Ex Date
2024-04-29
Competitors
Ranks
-
Novo Nordisk A/S
00%
-
AstraZeneca PLC
00%
-
Bayer AG
00%
-
Eli Lilly and Co
00%
-
Roche Holding AG
00%
-
Merck KGaA
00%
-
Dermapharm Holding SE
00%
-
Novartis AG
00%
-
Johnson & Johnson
00%
-
Merck & Co Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Germany
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals
Sub-sector
Health Care
Capitalization (millions of $)
71616.7
Ticker
MKKGY.PK
ISIN
US5893392093
IPO date
1995-10-20
Availability on Russian exchanges
Yes
Reporting for
2024-03-07
Date fact. publication of reports
2023-12-31
Company Description
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Performance Materials. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Performance Materials business provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: